Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.58 $5.85 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Dec 30, 2016 $11.08 $11.14 $10.75 $10.99 44 009
Dec 29, 2016 $11.35 $11.67 $11.03 $11.12 31 218
Dec 28, 2016 $11.37 $11.54 $11.03 $11.32 68 505
Dec 27, 2016 $12.34 $12.34 $11.20 $11.26 83 222
Dec 23, 2016 $11.66 $12.44 $11.64 $12.34 103 760
Dec 22, 2016 $11.56 $11.80 $11.28 $11.60 60 819
Dec 21, 2016 $11.60 $11.76 $11.20 $11.51 67 514
Dec 20, 2016 $11.77 $11.79 $11.37 $11.50 93 116
Dec 19, 2016 $12.00 $12.51 $11.58 $11.74 112 071
Dec 16, 2016 $11.70 $12.17 $11.70 $11.95 171 487
Dec 15, 2016 $11.54 $12.06 $11.30 $11.64 99 427
Dec 14, 2016 $11.69 $11.81 $11.23 $11.45 72 932
Dec 13, 2016 $11.70 $12.19 $11.18 $11.53 126 411
Dec 12, 2016 $12.25 $12.25 $11.61 $11.67 82 665
Dec 09, 2016 $12.31 $12.92 $12.22 $12.25 80 030
Dec 08, 2016 $12.12 $12.21 $11.69 $12.18 85 354
Dec 07, 2016 $12.16 $12.30 $11.87 $12.12 77 019
Dec 06, 2016 $12.35 $12.44 $11.78 $12.28 242 648
Dec 05, 2016 $11.13 $11.49 $11.08 $11.48 98 914
Dec 02, 2016 $10.30 $11.28 $10.03 $11.00 143 802
Dec 01, 2016 $11.00 $11.00 $10.11 $10.21 267 638
Nov 30, 2016 $11.10 $11.35 $10.87 $11.14 159 712
Nov 29, 2016 $11.27 $11.36 $11.06 $11.10 95 279
Nov 28, 2016 $11.68 $11.84 $11.08 $11.28 125 650
Nov 25, 2016 $12.03 $12.07 $11.63 $11.81 36 468
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT